London, England, Jan. 13, 2023 (GLOBE NEWSWIRE) — Flooid today announces a strategic partnership with Read more »
More Austerity in 2023 Will Fuel Protests
Anti-Austerity [...] Read more »
The Myth of the “Moderate Republican” — and Why It’s So Dangerous
US President [...] Read more »
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Avaya Holdings Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AVYA, AVYAW
NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Avaya [...] Read more »
Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines
WASHINGTON, Jan. 12, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi–year contract with funding potential for [...] Read more »
Taking Humanitarianism Hostage – the Case of Afghanistan & Multilateral Organisations
Women receive [...] Read more »
Indian PhD Students Say Long Australian Visa Delays Have Put Their Lives On Hold
![Indian doctoral students are [...] <a class=](https://www.ipsnews.net/Library/2023/01/thisisengineering-raeng-8yS04veb1TQ-unsplash-300x200.jpeg)
Read more »
GWH, GWH.WT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESS Tech, Inc. Investors to Inquire About Securities Class Action Investigation – GWH, GWH.WT
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate securities claims on behalf of shareholders of ESS [...] Read more »
PHAT INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom [...] Read more »
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Provident Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation – PVBC
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Provident [...] Read more »
CORZ IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Core Scientific, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 13 Deadline in Securities Class Action – CORZ
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Core Scientific, Inc. (NASDAQ: CORZ) between January 3, 2022 [...] Read more »
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bird Global, Inc. Investors to Secure Counsel Before Important January 17 Deadline in First Filed Securities Class Action Commenced by the Firm – BRDS
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bird Global, Inc. (NYSE: BRDS) between May 14, 2021 and [...] Read more »
E.C.D. Automotive Design’s Stunning LT4 Defender Defines Classic Romance
KISSIMMEE, Fla., Jan. 11, 2023 (GLOBE NEWSWIRE) — Read more »
Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)
Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients with IgG4–RD, a chronic and serious fibroinflammatory disease typically affecting multiple organs
[...] Read more »Security Policy is more than Defence with Weapons
2022 Year in [...] Read more »